Dr. Sevan V. Stepanian, MD

Dr. Stepanian practices at Facey Medical Group - Valencia Specialty & Women's Center in Valencia, California.

Dr. Stepanian's NPI, 1790941029, was assigned on August 6, 2008. Dr. Stepanian graduated from David Geffen School of Medicine at UCLA in 2007. Dr. Stepanian holds California license A108795.

Dr. Stepanian's primary practice is Facey Medical Group - Valencia Specialty & Women's Center, at 23803 McBean Parkway, Valencia, CA 91355. The practice phone is (818) 869-7034.

Dr. Stepanian's primary practice is Facey Medical Group - Valencia Specialty & Women's Center in Valencia, California. Dr. Stepanian is also affiliated with Henry Mayo Newhall Hospital. The medical group on file is Facey Medical Group. Dmand AI also links Dr. Stepanian to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stepanian practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Stepanian's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Stepanian is board certified in urology by the American Board of Urology. Dmand AI has Dr. Stepanian's licenses on file in 2 states: California and Washington.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate inflammation or infection among the conditions Dr. Stepanian treats.

CMS data shows 719 Medicare services from Dr. Stepanian across 14 procedure codes in 2024, for 267 Medicare patients. Medicare paid $52,032 for them.

CMS counts 267 Medicare patients who saw Dr. Stepanian in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stepanian's median patient age at 70, with 24% women.

In 2024, Dr. Stepanian wrote 1,142 Medicare Part D claims for 329 patients. 75% of them were for generic drugs. CMS names the drug for 1,015 of them, across 18 drugs with 11 or more claims each, at $221,058 in total drug cost. In 2023, CMS named 1,114 claims across 18 drugs.

Dr. Stepanian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stepanian as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Stepanian, published from 2007 to 2016. The most frequent topics are Blood Loss, Surgical, Carcinoma, Renal Cell and Kidney Neoplasms. Dr. Stepanian has published most often in Eur Urol. Dr. Stepanian's most frequent co-authors are Christopher Paul Filson, MD, MS, Jim C. Hu, MD, MPH and John S. Lam, MD.

CMS Open Payments shows 98 general payments to Dr. Stepanian from 35 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 40% of the total. Gyrus ACMI, Inc. paid the most, $5,229.

Dr. Stepanian graduated from David Geffen School of Medicine at UCLA in 2007. Dr. Stepanian is a member of AUA.

Dr. Stepanian is in network with 11 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.